Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Chs (CHSCL) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Chs (CHSCL) over the last 16 years, with Q4 2025 value amounting to $374.7 million.

  • Chs' Cash & Equivalents fell 1682.54% to $374.7 million in Q4 2025 from the same period last year, while for Nov 2025 it was $374.7 million, marking a year-over-year decrease of 1682.54%. This contributed to the annual value of $327.8 million for FY2025, which is 5875.7% down from last year.
  • Per Chs' latest filing, its Cash & Equivalents stood at $374.7 million for Q4 2025, which was down 1682.54% from $327.8 million recorded in Q3 2025.
  • In the past 5 years, Chs' Cash & Equivalents registered a high of $1.8 billion during Q3 2023, and its lowest value of $211.9 million during Q1 2022.
  • Moreover, its 5-year median value for Cash & Equivalents was $423.2 million (2021), whereas its average is $573.8 million.
  • As far as peak fluctuations go, Chs' Cash & Equivalents skyrocketed by 19328.26% in 2021, and later crashed by 6890.4% in 2024.
  • Quarter analysis of 5 years shows Chs' Cash & Equivalents stood at $310.0 million in 2021, then skyrocketed by 105.26% to $636.3 million in 2022, then soared by 112.13% to $1.3 billion in 2023, then plummeted by 66.62% to $450.5 million in 2024, then fell by 16.83% to $374.7 million in 2025.
  • Its Cash & Equivalents was $374.7 million in Q4 2025, compared to $327.8 million in Q3 2025 and $323.9 million in Q2 2025.